Ignite Creation Date:
2025-12-24 @ 10:32 PM
Ignite Modification Date:
2026-01-03 @ 6:56 AM
Study NCT ID:
NCT05743335
Status:
COMPLETED
Last Update Posted:
2024-09-19
First Post:
2023-02-22
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase 1 Study to Assess the Safety and Immunogenicity of JCXH-221, an MRNA-based Broadly Protective COVID-19 Vaccine
Sponsor:
Immorna Biotherapeutics, Inc.
Organization: